MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Sinemet 12.5mg/50mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Sinemet Plus 25mg/100mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 5mg tablets (Servier Laboratories Ltd).

Stability Notes

Store in airtight containers. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Flucloxacillin 500mg capsules (Milpharm Ltd).

Stability Notes

Store in airtight containers. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Flucloxacillin 250mg capsules (Milpharm Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.